Hyperbaric Oxygen Therapy Promotes Hearing Gain with Increases in Serum IGF-1 and HSP70 in Patients with Idiopathic Sudden Sensorineural Hearing Loss

OBJECTIVE: Hyperbaric oxygen therapy (HBOT) has been recommended for the initial and salvage treatment of patients with idiopathic sudden sensorineural hearing loss (ISSHL), but its underlying mechanisms remain unclear. In this study, we investigated whether HBOT alters serum levels of insulin-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Jia, Xingyuan, Liu, Xuehua, Zhao, Lin, Zhou, Yan, Liang, Fang, Gao, Yu, Yang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626202/
https://www.ncbi.nlm.nih.gov/pubmed/36330225
http://dx.doi.org/10.1155/2022/1368783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626202/
https://www.ncbi.nlm.nih.gov/pubmed/36330225
http://dx.doi.org/10.1155/2022/1368783

Ejemplares similares